• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MEDTRONIC IRELAND RESOLUTE INTEGRITY RX; STENT, CORONARY, DRUG-ELUTING Back to Search Results
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Embolism (1829); Thrombus (2101)
Event Date 07/02/2019
Event Type  Injury  
Manufacturer Narrative
Journal article: restenosis rates after drug-eluting stent treatment for stenotic small-diameter renal arteries.Title: cardiovascular and interventional radiology year: 2019 ref: https://doi.Org/10.1007/s00270-019-02264-z.Average age, majority,gender.Date of publication.Concomitant medical products: statins, antiplatelet agents, angiotensin-converting enzyme inhibitors (aceis), and angiotensin receptor blockers (arbs).If information is provided in the future, a supplemental report will be issued.
 
Event Description
It was reported in a journal article that 37 patients in a study from june 2004 to may 2017 received drug eluting stents to treat main and segmental renal artery stenosis.Among these stents one resolute integrity rx drug eluting stent was used.The device was successfully implanted.Adverse events experienced included in-stent restenosis, all cause death, renal artery embolization, in situ thrombosis.Both the thrombus and the embolism were successfully treated with intra-arterial thrombolysis with tissue plasminogen activator.It was reported that one death occurred within 30 days, which was not related to the renal artery stent procedure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
RESOLUTE INTEGRITY RX
Type of Device
STENT, CORONARY, DRUG-ELUTING
Manufacturer (Section D)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer (Section G)
MEDTRONIC IRELAND
parkmore business park west
galway
Manufacturer Contact
toni o'doherty
parkmore business park west
galway 
091708734
MDR Report Key9178499
MDR Text Key161991323
Report Number9612164-2019-04312
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P110013
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial
Report Date 10/11/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received10/11/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received09/18/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Hospitalization; Required Intervention;
Patient Age73 YR
-
-